Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CrCl3-catalyzed route for (S)-phenylglycinol hydrochloride. Enhances purity and reduces costs for pharmaceutical intermediate manufacturing.
Patent CN102586384B reveals a novel deracemization method for D-amino acids using Alcaligenes faecalis, offering high optical purity and simplified downstream processing for pharmaceutical supply chains.
Patent CN113480521B details a novel synthesis route for Bepotastine Besilate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN102603607A details a cost-effective route for (R)-Oxiracetam using ion exchange purification. Achieve >98.5% purity with scalable, eco-friendly manufacturing processes.
Patent CN103145698B reveals high-purity Rivaroxaban intermediate synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing.
Novel preparation of (3aS, 6aR)-1,3-dibenzyltetrahydro-4H-thieno[3,4-d]imidazol-2,4-(1H)-dione via cystine ester. Eliminates expensive alkaloids and harsh thio-reagents for scalable vitamin H production.
Patent CN106588739A reveals a Vitamin C-based synthesis for high-purity Trans-3-hydroxy-L-proline. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106588739A details a high-purity Trans-3-hydroxy-L-proline method using Vitamin C. This report analyzes cost reduction in API intermediate manufacturing and supply chain reliability.
Patent CN101575298B details a cost-effective synthesis of chiral 2-amino-1-phenylethylalcohol from styrene glycol, offering high optical purity for beta-agonist manufacturing.
Patent CN108409639B details a novel chiral synthesis route eliminating resolution agents. Achieve significant cost reduction and supply reliability for cardiovascular intermediates.
Novel synthesis route for Alvimopan intermediates via CN102127005A. Offers high purity, chiral control, and cost-effective API manufacturing solutions.
Patent CN107540574B reveals a cost-effective D-tyrosine route for R-biphenylalaninol, offering high purity and scalable production for Entresto intermediates.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Advanced preparation method for optically pure 2-methyl alkyl glycol derivatives from lactones. Enables scalable production of chiral synthetic building blocks for pharmaceutical and agrochemical intermediates.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
Patent CN105061393B reveals a novel route for (S)-(-)-3-methylamino-1-(2-thienyl)-1-propanol, offering >99% purity and >80% yield for scalable duloxetine production.
Patent CN109438432B details a green emtricitabine synthesis using L-menthol. Offers cost reduction in antiviral API manufacturing and high-purity intermediates.
Novel patent CN117510393A details efficient synthesis of chiral indoline derivatives. This method offers significant cost reduction and supply chain reliability for API manufacturing partners.
Patent CN1923792A reveals a cost-effective synthesis for HMG-CoA reductase inhibitor intermediates, offering scalable production and superior optical purity for global supply chains.
Patent CN107176913A details novel binaphthol derivatives enabling stable hydrogels. This report analyzes supply chain reliability and cost reduction in surfactant manufacturing.